Current evidence supports a model in which RB1 and TP53 loss establishes a chromatin state permissive for lineage switching, but additional tumor cell-extrinsic signals from the TME are needed to initiate and sustain lineage plasticity. The gene discussed is RB1; the disease is neoplasm.